Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1965 of 6351
-
New immunotherapy shot targets tumors with many mutations
Disease control Recruiting nowAn open, single-arm, multi-center Phase II clinical study of ENVAFOLIMAB single-agent treatment in patients with advanced solid tumors,to compare the overall response rate of TMB-high and TMB-Low,to determine the cut off value between TMB-high and TMB-Low of diagnosis device.Then…
Phase 2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for liver cancer patients: which procedure best prevents dangerous rebleeding?
Disease control OngoingSP by EUS-CYA improves clinical outcomes (eg, EV rebleeding) in patients with HCC and prior EV bleeding when compared with SP by EGD-VBL
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New vaccine combo aims to control advanced head and neck cancer
Disease control OngoingThis is a phase Ib study with a safety lead-in (n = 6 per arm) evaluating combinatorial DPV-001 + sequenced PD-1 blockade, with or without GITR agonist, in recurrent or metastatic HNSCC.
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Vacuum bandage may slash infection risk after GI cancer surgery
Disease control CompletedThis randomized trial will use a Negative Pressure Wound Therapy device or standard wound closure, in participants with gastrointestinal neoplasms, to measure the rate of surgical site infections
Phase 2/3 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Prostate cancer radiation gets a boost: MR-Guided trial aims to halve recurrence
Disease control OngoingOne of the usual approaches to treating intermediate-risk prostate cancer is a type of radiation therapy called SBRT (stereotactic body radiation therapy). SBRT delivers higher than standard doses of radiation over a lower number of treatment sessions. However, there is a 20% cha…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Phone coaching may curb Long-Term pain after joint surgery
Symptom relief CompletedThis study will trial the impact of teaching surgical patients a pain self-management approach to compliment medical post-surgical pain management.
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Immunotherapy duo after radiation shows promise for untreatable liver cancer
Disease control OngoingThis phase Ib trial investigates the side effects of durvalumab and tremelimumab after radioembolization (radiation particles against liver tumors) and to see how well they work in treating patients with liver cancer that cannot be removed by surgery (unresectable) and has spread…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control CompletedPatients with advanced tumors diagnosed histologically or cytologically at the study center who were refractory to standard therapy or had relapsed received XNW5004 tablets
Phase 1/2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Exercise at home may restore low blood sugar warning signs in type 1 diabetes
Symptom relief CompletedThe objective of this study is to investigate if the addition of a 12-week program of home-based high intensity interval training to a standard educational program aiming at preventing hypoglycemia episodes will restore hypoglycemia awareness in people living with type 1 diabetes…
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Diabetes duo: new combo shot shows promise for blood sugar
Disease control CompletedThis study looks at how well a new medicine called cagrilintide works together with semaglutide on blood sugar levels in people with type 2 diabetes compared to cagrilintide alone or semaglutide alone. Before a new medicine can be prescribed to people it needs to be tested to se…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a new pill calm Autism-Related irritability?
Symptom relief CompletedThe purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in participants with irritability associated with autism spectrum disorder.
Phase 2 • Sponsor: Vertero Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-101/GI-101A as a single agent or in combination with pembrolizumab or lenvatinib over a range of advanced and/or metastatic solid tumors.
Phase 1/2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New needle technique may spare breast cancer patients from surgery
Disease control CompletedThis study will assess whether it is feasible to remove small breast cancers completely using the Vacuum Assisted Biopsy (VAB) system System under Ultrasound guidance.
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Healing after loss: can talk therapy lift depression?
Symptom relief CompletedThis study tests the efficacy of interpersonal psychotherapy (IPT) for major depression following perinatal loss (early and late fetal death and early neonatal death) in a sample of 274 women in Flint and Detroit, Michigan. The trial will be the first fully powered randomized tri…
Sponsor: Michigan State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
No-Needle liver test: MRI may replace painful biopsies
Diagnosis CompletedChronic liver disease is a major healthcare problem in Hong Kong and worldwide. The diagnosis of liver fibrosis and inflammation in patients with chronic liver disease has important prognostic and therapeutic implications. The current gold standard to evaluate and stage the sever…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Light therapy shows promise for Schizophrenia's toughest symptoms
Symptom relief CompletedAbstract: Randomized clinical trial that aims to see the efficacy of photoneuromodulation for the treatment of negative symptoms of schizophrenia in patients refractory to transcranial direct current stimulation. In this group of 30 refractory volunteers, magnetic resonance spect…
Phase 2 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Brain bleed breakthrough? new procedure aims to stop clots from returning
Disease control OngoingEMMA-Can is a prospective randomized open-label, blinded end point (PROBE) study, that will assess the recurrence risk and safety of embolization of the middle meningeal (EMMA) when added to standard of care treatment (surgical drainage) of chronic subdural hematoma (CSDH) compar…
Sponsor: University of Manitoba • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Robot and electrical zaps at home could boost stroke recovery
Disease control Recruiting nowThe investigators have developed a novel robot-guided stretching under intelligent control and combine it with active movement training, which helped increase joint ROM, reduce spasticity and joint stiffness, increase muscle force output, and improve locomotion. However, for stro…
Phase 1/2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Muscle relaxants may boost oxygen in severe COVID-19 lung failure
Disease control CompletedMany questions about management of COVID-19 are still not answered. So, we recruit this study aiming to evaluate improvement of oxygenation in COVID-19 patients with severe ARDS, to improve morbidity and mortality of ICU covid patients, to participate in understanding of real hid…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Experimental drug combo targets tough bone cancer
Disease control CompletedThis is a phase 1/2 study of azenosertib (ZN-c3) in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.
Phase 1 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC